Center for Medicinal Cannabis Research

Closed portfolio with an early-phase archive tilt

According to ClinicalTrials.gov-derived indexes, Center for Medicinal Cannabis Research sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).

9 total trials none currently recruiting 7 completed early-phase tilt top decile by trial count

Center for Medicinal Cannabis Research: 9 sponsored US clinical trials, none currently recruiting.

Center for Medicinal Cannabis Research sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 7 completed. 0 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hyperalgesia, with 1 trials.

Top-decile sponsor footprint

Center for Medicinal Cannabis Research ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Indexed trials (enrollment closed)

9 total, page 1 of 1

COMPLETED Phase 1

Efficacy of Inhaled Cannabis in Diabetic Painful Peripheral Neuropathy

NCT00781001
COMPLETED Phase 1

Vaporization as a Smokeless Cannabis Delivery System

NCT00241592
COMPLETED Phase 1

Effects of Smoked Marijuana on Neuropathic Pain

NCT00254761
TERMINATED Phase 1

Cannabis for Spasticity in Multiple Sclerosis

NCT00260741
COMPLETED Phase 1

Marijuana for HIV-Related Peripheral Neuropathy

NCT00046722
TERMINATED Phase 1

Marijuana for Cancer Pain

NCT00046709
COMPLETED Phase 1

Analgesic Efficacy of Smoked Cannabis

NCT00241579
COMPLETED Phase 1

Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis

NCT00248378
COMPLETED Phase 1

Medicinal Cannabis for Painful HIV Neuropathy

NCT00255580

Phase Distribution

PhaseTrial count
Phase 1 9

Therapeutic Areas

Hyperalgesia 1
Neuropathic Pain 1
HIV Infections 1
Peripheral Nervous System Diseases 1
Pain 1

How the Center for Medicinal Cannabis Research early-phase archive is shaped

9 indexed studies, none listed as recruiting (0% open); 7 completed (78%).

Phase mix: 0 late (III/IV) vs 9 early (I/II) (early-phase heavy).

Top condition: Hyperalgesia (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Center for Medicinal Cannabis Research: archived-pipeline peers nationwide

Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Center for Medicinal Cannabis Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%10%20%30%40%50% Total trials Recruiting share Center for Medicinal Cannabis Research4D Molecular Therapeutics9 Meters BiopharmaAadi BioscienceAblynx, a Sanofi company10xBio22nd Century Group23andMe3-C Institute for Social Development
Center for Medicinal Cannabis Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Center for Medicinal Cannabis Research sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 9 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Center for Medicinal Cannabis Research page

9 registered trials is a research-attention snapshot, not an endorsement of Center for Medicinal Cannabis Research or any single study.

  • None of Center for Medicinal Cannabis Research's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Hyperalgesia is the condition Center for Medicinal Cannabis Research studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hyperalgesia trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Center for Medicinal Cannabis Research pipeline card: 9 registered trials from official public datasets.Report a data error.